Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03820973 · ClinicalTrials.gov registry record · NA

Brief Cognitive Behavioral Therapy for Anxiety

A NA study of Anxiety, sponsored by Michael E. DeBakey VA Medical Center.

Completed
Registry status
NA
Development phase
18
Enrollment target
1
Study location

NCT03820973: Completed NA study of Anxiety, sponsored by Michael E. DeBakey VA Medical Center.

NCT03820973 is a NA study of Anxiety that has completed, run by Michael E. DeBakey VA Medical Center. The registered enrollment target is 18 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03820973, a NA study of Anxiety, has completed, sponsored by Michael E. DeBakey VA Medical Center.

COMPLETED
Registry status
NA
Development phase
18 participants
Enrollment target
1
Study location

Study Summary

The proposed clinical intervention is a modular skills-based intervention for flexible delivery of care, measurement-based care practices, and integration of exposure strategies critical for anxiety symptom reduction. Notably, the treatment targets anxiety symptoms rather than diagnoses to improve use in PCMHI and CBOC settings. The pilot study will develop and conduct preliminary testing of bCBT for anxiety using Veterans Affairs (VA) Video Connect to Home (VVC-H) to deliver care.

Primary Outcome

scale used to measure anxiety, scores range from 0 to 21, where higher scores equal higher levels of anxiety.

Conditions Studied

Interventions

  • BEHAVIORAL Brief CBT for Anxiety

Study Locations (1)

Texas

  • Michael E. DeBakey VAMC - Houston

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2019-02-01
Est. Completion 2021-09-01
Phase NA

What the finished NCT03820973 record still lists

NCT03820973 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Anxiety appearing as the primary indexed condition, and to 1 intervention - of which Brief CBT for Anxiety is the first listed.

NCT03820973 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT03820973 about?

NCT03820973 is a clinical study titled "Brief Cognitive Behavioral Therapy for Anxiety". The proposed clinical intervention is a modular skills-based intervention for flexible delivery of care, measurement-based care practices, and integration of exposure strategies critical for anxiety symptom reduction. Notably, the treatment targets anxiety symptoms rather than diagnoses to improve u...

What is the current status of trial NCT03820973?

This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2019-02-01. Estimated completion is 2021-09-01.

What conditions does trial NCT03820973 study?

This clinical trial studies the following conditions: Anxiety.

What interventions are being tested in trial NCT03820973?

The interventions under investigation include: Brief CBT for Anxiety (BEHAVIORAL).

Who is sponsoring clinical trial NCT03820973?

This trial is sponsored by Michael E. DeBakey VA Medical Center, which has 16 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03820973 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03820973's enrollment target sits among peer trials

18 334th of 364 higher than 27 of 364 other Anxiety trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01245179 · 18 participants · Phase 1

    Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease

  • NCT01999361 · 18 participants · NA

    Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss

  • NCT02359825 · 18 participants · Phase 1

    Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function

  • NCT02870244 · 18 participants · Phase 1

    Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03820973, the US trial registry maintained by the National Library of Medicine. NCT03820973 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.